Lenvatinib and Impurities
Ref: 4Z-L-124060
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Ref: 4Z-L-124010
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Ref: 4Z-L-124023
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Lenvatinib mesylate
CAS:857890-39-2
Lenvatinib mesylate (E7080 (mesylate)) is an oral and multi-targeted inhibitor of VEGFR1-3, FGFR1-4, PDGFR, KIT, …
Formula:
C22H23ClN4O7S
Purity:
99.03% - 99.79%
Color and Shape:
Solid
Molecular weight:
522.96
Ref: TM-T8541
10mg | 40.00 € | ||
25mg | 59.00 € | ||
50mg | 87.00 € | ||
100mg | 109.00 € | ||
200mg | 162.00 € | ||
500mg | 263.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Lenvatinib
Controlled ProductCAS:417716-92-8
Applications Lenvatinib is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF …
Formula:
C21H19ClN4O4
Color and Shape:
White To Beige
Molecular weight:
426.85
Ref: TR-L329400
5mg | 132.00 € | ||
25mg | 526.00 € | ||
100mg | 1,368.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024